Company Press Releases 16 Jul 2024 FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG) 31 Jan 2023 FLAG Therapeutics Receives Rare Pediatric Disease (RPD) Designation for FLAG-003 for the Treatment of Children with Diffuse Intrinsic Pontine Glioma (DIPG) 8 Aug 2017 FLAG Therapeutics Oversubscribes Financing Round and Receives $500,000 Matching Loan From North Carolina Biotechnology Center 29 Feb 2016 FLAG Therapeutics Granted Orphan Drug Designation for FLAG-003 for the Treatment of Glioma FLAG in the News 17 Nov 2019 NEW PANCREATIC CANCER TREATMENT TARGETS ONLY TUMOR CELLS
